Substance use disorder

• 1. Diagnostic Evolution And Criteria

  ›

  The year 2013 marked a pivotal shift in how doctors classify substance use disorders. The American Psychiatric Association merged two previous diagnoses, substance abuse and substance dependence, into a single category called substance use disorder within the DSM-5 manual. This change acknowledged that addiction exists on a spectrum rather than as a binary state of being either an abuser or dependent. Clinicians now assess severity based on how many of eleven specific criteria a patient meets. A diagnosis of mild substance use disorder requires only two or three of these criteria to be present. Moderate cases involve four or five criteria, while severe cases are defined by six or more symptoms. These criteria cover issues ranging from loss of control over use to hazardous situations like driving under the influence. The term drug addiction is now synonymous with severe substance use disorder in this updated framework.

  168

• 2. Biopsychosocial Etiology Factors

  ›

  Children born to parents with a substance use disorder face roughly double the risk of developing their own disorder compared to children without such family history. Biological factors include genetics and developmental life stages that shape vulnerability. Social determinants play an equally critical role, including adverse childhood experiences and socioeconomic conditions. Research conducted in 2021 found a direct connection between traumatic childhood events and future substance abuse rates. Adolescents who begin using alcohol or drugs before age twenty-five show higher likelihoods of adult disorders. Psychological traits like high impulsivity and sensation seeking also contribute to risk profiles. Social circumstances such as unemployment create cycles where stress leads to increased substance use which then worsens employment prospects. Family dynamics matter significantly since SUD often damages relationships leading to divorce or government intervention through agencies like Child Protective Services.

  242931

• 3. Global Epidemiology And Mortality

  ›

  In 2017 global estimates placed 271 million people aged fifteen and older as users of illicit drugs representing five point five percent of the adult population worldwide. Of these individuals thirty-five million met criteria for a substance use disorder. Alcohol use disorder affected two hundred thirty-seven million men and forty-six million women by 2016 statistics. Substance use disorders from illicit substances directly caused five hundred eighty-five thousand deaths globally that same year. Deaths from drug use excluding alcohol rose over sixty percent between 2000 and 2015 alone. Alcohol consumption resulted in an additional three million deaths in 2016. In the United States alone over seventy-two thousand overdose deaths occurred in 2017 marking a threefold increase from 2002 figures. Synthetic opioids containing fentanyl contributed nearly thirty thousand deaths annually while heroin and other natural opioids added roughly thirty-one thousand fatalities. Tobacco remains the leading cause of preventable death responsible for more than four hundred eighty thousand deaths each year in America.

  187980

• 4. Clinical Management Strategies

  ›

  Withdrawal management provides medical and psychological care for patients experiencing symptoms after ceasing drug use. Acute withdrawal from heavy alcohol use requires strict medical supervision to prevent delirium tremens which can be fatal. Behavioral therapies like cognitive behavioral therapy help individuals identify harmful thought patterns influencing emotions negatively. Motivational interviewing techniques assist doubtful patients in finding motivation to change their behavior. Medication-assisted treatment combines behavioral interventions with specific drugs approved for severe cases. Five medications currently treat alcohol and opioid use disorders within the United States though none exist for cocaine or methamphetamine yet. Methadone and disulfiram help patients function comfortably without illicit substances by lessening withdrawal symptoms. Evidence demonstrates medication-assisted treatment reduces illicit drug use and overdose deaths while improving retention rates in treatment programs. About eleven percent of Americans with substance use disorder seek treatment but forty to sixty percent relapse within one year.

  51464849

• 5. Emerging Pharmacological Research

  ›

  Scientists have investigated addiction vaccines since the early 2000s as a potential method to immunize against specific substances. These experimental treatments condition the immune system to attack molecules causing reactions in the brain thereby preventing addicts from realizing drug effects. NicVAX represents a conjugate vaccine developed by Nabi Biopharmaceuticals intended to reduce physical dependence on nicotine. TA-CD is an active vaccine created by Xenova Group designed to negate cocaine effects by combining norcocaine with inactivated cholera toxin. This approach prevents cocaine from crossing the blood-brain barrier negating euphoric highs caused by dopamine release in the mesolimbic reward pathway. As of September 2023 reports indicated testing had begun against heroin and fentanyl with plans to test against oxycontin soon. Vaccines offer long duration of action and certainty of administration compared to other anti-addiction treatments currently available.

  717063